StockTipsArenaBeta

BUY MOLBIO DIAGNOSTICS LTD — Jefferies India

BUYMOLBIO DIAGNOSTICS LTD
MOLBIO DIAGNOSTICS share price target & all analyst calls

byJefferies IndiaHorizon: NA (inferred 1 year)30 Sept 2026via LiveMint Markets

Entry₹1,314.9Inferred
Target₹1,600
Total upside +21.68% (call closed)
Stop lossNot given
Exit₹1,60016 Oct 2026, 12:10 pm
Target hit+21.68%0.00%upside left
Follow Jefferies India for new calls(98% target hit, 63 closed calls)Get alertsWatch MOLBIO for new buy/sell callsGet alertsSee 2 active Long-term calls on MOLBIOSee 542 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 16 Oct 2026
12 supporting2 neutral2 opposing
Supports the BUY call (12)

Broker’s call: Molbio Diagnostics (Buy)

NewsHbl·7 Oct · 1w ago

(opens in new tab)

Motilal Oswal initiates coverage on Molbio Diagnostics stock with Buy, sees 21% upside. Here's why

NewsEt-Markets·6 Oct · 1w ago

(opens in new tab)

Molbio Diagnostics Shares In Focus As Motilal Oswal Initiates Coverage; Check Target Price

NewsNdtv-Profit·5 Oct · 2w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·5 Oct · 2w ago

Molbio Diagnostics shares jump 5% as HDFC MF buys 1.99% stake via bulk deal | Newly listed stock up 71% from IPO price

NewsLivemint·1 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

Motilal Oswal Alternates sells over 2% stake in Molbio Diagnostics for ₹306 cr

NewsHbl·1 Oct · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on MOLBIO DIAGNOSTICS

All analyst calls on MOLBIO DIAGNOSTICS

More from Jefferies India

Every call and its outcome